Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
Sodium chloride; Glucose - anhydrous; Glucose (anhydrous)
Fresenius Kabi Australia Pty Limited
Medicine Registered
Sodium Chloride and Glucose IV Infusion Product Information NaCl Glucose PI Amended 080915 Page 1 of 8 Baxter SODIUM CHLORIDE (%) AND GLUCOSE (%) INTRAVENOUS INFUSION BP NAME OF THE DRUG Sodium Chloride (%) and Glucose (%) Intravenous Infusion BP Composition of the active ingredients: Glucose (anhydrous) and Sodium Chloride in water for injection. The chemical name of glucose is D-(+) glucopyranose. Molecular formulae of glucose and sodium chloride is C 6 H 12 O 6, and NaCl, respectively. Chemical Structure: DESCRIPTION Glucose is a monosaccharide, having physical characteristics as a white crystal or granular powder and freely soluble in water. Sodium chloride occurs as a colourless or white crystal and is freely soluble in water. The Sodium Chloride (%) and Glucose (%) Intravenous Infusion preparations are a sterile, nonpyrogenic solution. The concentrations of the active ingredients dissolved in a litre of water for injection are shown in Table 1 (see Presentation). They do not contain an antimicrobial agent or added buffer and have a pH of 3.5 - 6.5. They are iso-osmotic as indicated by their osmolarity shown in Table 1, except glucose (5.0%) in sodium chloride (0.9%) with Osmolarity of 585.0 mOsmol/L, and glucose (10%) in sodium chloride (0.22%) with osmolarity of 630.0 mOsmol/L. PHARMACOLOGY Mechanism of Action: Glucose is readily metabolised into carbon dioxide and water, with a release of energy. As such, an administration of a glucose solution either by oral or parenteral route provides water for body hydration as well as energy (see Table 1 for conversion to kJoules unit). In addition, it may reduce catabolic loss of nitrogen from the body and aid in prevention of depletion of liver glycogen. That is, in the absence of glucose, amino acids undergo deam Lue koko asiakirja